Fact Sheet: Multisystem Inflammatory Syndrome in Children (Mis-c) - New York City

Fact Sheet: Multisystem Inflammatory Syndrome in Children (Mis-c) is a legal document that was released by the New York City Department of Health and Mental Hygiene - a government authority operating within New York City.

FAQ

Q: What is Multisystem Inflammatory Syndrome in Children?
A: Multisystem Inflammatory Syndrome in Children (MIS-C) is a rare but serious condition that affects children and young adults.

Q: What are the symptoms of MIS-C?
A: Symptoms of MIS-C can include fever, rash, abdominal pain, vomiting, diarrhea, and red eyes.

Q: Is MIS-C contagious?
A: No, MIS-C is not contagious.

Q: How is MIS-C treated?
A: Treatment for MIS-C usually involves hospitalization and close monitoring. It may include medications to reduce inflammation and support organ function.

Q: Is MIS-C dangerous?
A: MIS-C can be serious and may require intensive care, but most children with MIS-C recover with medical care.

Q: How can MIS-C be prevented?
A: The best way to prevent MIS-C is by practicing good hygiene, wearing masks, and following other COVID-19 safety guidelines.

Q: Is there a vaccine for MIS-C?
A: No, there is currently no vaccine specifically for MIS-C, but getting vaccinated against COVID-19 can help reduce the risk of developing MIS-C.

Q: Is MIS-C only found in New York City?
A: No, MIS-C has been reported in other parts of the United States and in other countries as well.